Department of Cardiology, Larissa University Hospital, P.O. Box 1425, 41110 Larissa, Greece.
Cardiol Res Pract. 2012;2012:410820. doi: 10.1155/2012/410820. Epub 2012 Jun 7.
Heart failure (HF) is a growing epidemic with the annual number of hospitalizations constantly increasing over the last decades for HF as a primary or secondary diagnosis. Despite the emergence of novel therapeutic approached that can prolong life and shorten hospital stay, HF patients will be needing rehospitalization and will often have a poor prognosis. Telemonitoring is a novel diagnostic modality that has been suggested to be beneficial for HF patients. Telemonitoring is viewed as a means of recording physiological data, such as body weight, heart rate, arterial blood pressure, and electrocardiogram recordings, by portable devices and transmitting these data remotely (via a telephone line, a mobile phone or a computer) to a server where they can be stored, reviewed and analyzed by the research team. In this systematic review of all randomized clinical trials evaluating telemonitoring in chronic HF, we aim to assess whether telemonitoring provides any substantial benefit in this patient population.
心力衰竭（HF）是一种日益流行的疾病，在过去几十年中，HF 作为主要或次要诊断的住院人数不断增加。尽管出现了新的治疗方法，可以延长生命并缩短住院时间，但 HF 患者仍需要再次住院，且预后通常较差。远程监护是一种新的诊断方式，被认为对 HF 患者有益。远程监护被视为通过便携式设备记录生理数据（如体重、心率、动脉血压和心电图记录），并通过电话线、移动电话或计算机将这些数据远程传输（传输）到服务器的一种方式，以便可以由研究团队存储、审查和分析这些数据。在这项对所有评估远程监护在慢性 HF 中的随机临床试验的系统评价中，我们旨在评估远程监护是否为该患者人群提供任何实质性益处。
